November 2020
Earle A. Chiles Research Institute, a division of Providence Cancer Institute in the Robert W. Franz Cancer Center, is currently conducting more than 150 research studies, including clinical trials of targeted therapies and novel immunotherapy approaches.
New studies aim to improve treatments for advanced breast cancer
Advancements in treatment and early detection have improved survival for women diagnosed with breast cancer. For patients with locally advanced or metastatic breast cancer, better therapies are needed. Two new studies at Providence Cancer Institute seek to improve treatment options for patients with advanced breast cancer:
 
  • A Study of Tucatinib Plus Trastuzumab Deruxtecan in HER2+ Breast Cancer (HER2CLIMB-04)
 
  • A Study of GDC-0077 versus Placebo plus Palbociclib and Fulvestrant in PIK3CA-Mutant, HR+, HER2- Breast Cancer
All current open studies:
Find additional studies for many types of cancer in Multiple Tumor Types.
New studies are posted frequently - please check our website for a complete list of our current studies. For more information, call 503-215-2614.